Where is the live CopyMark page for USPTO serial 99860471?

The live record is at https://getcopymark.com/trademark/99860471. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns VISORY HEALTH PHARMA?

According to the public USPTO record for serial number 99860471, the listed owner(s) include: Visory Health, LLC.

What is USPTO serial number 99860471?

Serial number 99860471 is the USPTO application identifier for the mark VISORY HEALTH PHARMA. It is used to track examination, publication, and registration of this trademark.

What is the current status of VISORY HEALTH PHARMA?

VISORY HEALTH PHARMA (99860471) currently shows USPTO status code 681 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover VISORY HEALTH PHARMA?

The public record lists International Classes: 035, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: VISORY HEALTH PHARMA Serial# 99860471 | status 681; last event NONP | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VISORY HEALTH PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Visory Health, LLC
Chesterfield, MO, US
Other trademarks owned by Visory Health, LLC

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis JM Donahue III

Dennis JM Donahue III CARMODY MACDONALD P.C.120 S. Central Ave., Suite 1800TM Matter - Refer Notice to D. DonahueSt. Louis, MO 63105

Goods and services

Class	Description	Status	First use
035	Offering business management assistance in the establishment and/or operation of direct-to-consumer pharmaceutical programs; Analyzing and compiling business data for direct-to-consumer pharmaceutical programs; Business consulting services in the field of pharmacy services	ACTIVE	May 22, 2026
042	Providing temporary use of a web-based software application for patient communication for sending and receiving electronic messages, accessing patient educational resources, accessing information relating to patient financial assistance support, accessing pharmaceutical pricing tools, coupon management, and discount prescription card management; Platform as a service (PAAS) featuring computer software platforms for direct-to-consumer pharmaceutical programs for accessing pharmaceutical information, ordering pharmaceuticals, tracking pharmaceutical shipments, patient communication for sending and receiving electronic messages, accessing patient educational resources, accessing information relating to patient financial assistance support, accessing pharmaceutical pricing tools, coupon management, and discount prescription card management	ACTIVE	May 22, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 4, 2026	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Oct 15, 2026	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 14, 2026	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 14, 2026	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 14, 2026	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2026	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2026	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2026	DOCK	ASSIGNED TO EXAMINER	—
Oct 5, 2026	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 2, 2026	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jun 2, 2026	NWAP	NEW APPLICATION ENTERED	—

VISORY HEALTH PHARMA